Literature DB >> 9472960

Altered morning and nighttime pulsatile corticotropin and cortisol release in polycystic ovary syndrome.

C Invitti1, M De Martin, G Delitala, J D Veldhuis, F Cavagnini.   

Abstract

An overdrive of the hypothalamic-pituitary-adrenal (HPA) axis has been postulated in patients with polycystic ovary syndrome (PCOS). However, little is known concerning the pulsatile modes of corticotropin (ACTH) and cortisol secretion in these patients. To further investigate this issue, spontaneous ACTH and cortisol release were evaluated in 16 normal-weight patients with PCOS and 16 control women. Nine PCOS patients and eight controls were studied between 8 AM and 12 AM (noon), and seven PCOS patients and eight controls between 11 PM and 3 AM. Venous blood samples were taken at 10-minute intervals. Cluster analysis was used to assess ACTH and cortisol pulse frequency and amplitude, deconvolution to calculate mean hormone secretion rates, and approximative entropy (ApEn) to measure the orderliness of ACTH and cortisol time-series data. PCOS patients compared with controls displayed increased ACTH and cortisol release (area under the curve [AUC] and mean plasma concentration) both in the morning and at night. This was not due to increased hormonal secretory burst frequency, but to higher hormonal interpeak valley concentrations and, in the case of ACTH, nighttime pulse amplitudes. Mean ACTH and cortisol secretion rates also were increased in PCOS patients. Further, both controls and PCOS patients exhibited significant (0 to 20 minutes lagged) concordance between individual daytime pulsatile ACTH and cortisol release episodes. As shown by increased ApEn values, PCOS patients had more disorderly daytime cortisol release. In addition, the normal daytime correlation between the amount of pulsatile ACTH and cortisol release as observed in the controls was lost in PCOS patients. Finally, cross-correlation analysis showed a more prominent negative correlation in PCOS patients versus controls between plasma cortisol and 40- to 120-minute delayed ACTH concentrations in the morning, indicating a more sustained negative feedback of cortisol on ACTH release in PCOS at this time. Taken together, these findings demonstrate the existence of multifaceted dysregulation of the HPA axis in PCOS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472960     DOI: 10.1016/s0026-0495(98)90210-4

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

Review 1.  Polycystic ovary syndrome in adolescence.

Authors:  Colleen Buggs; Robert L Rosenfield
Journal:  Endocrinol Metab Clin North Am       Date:  2005-09       Impact factor: 4.741

Review 2.  Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis.

Authors:  Johannes D Veldhuis; Animesh Sharma; Ferdinand Roelfsema
Journal:  Endocrinol Metab Clin North Am       Date:  2013-03-13       Impact factor: 4.741

3.  Pulsatile Cortisol Feedback on ACTH Secretion Is Mediated by the Glucocorticoid Receptor and Modulated by Gender.

Authors:  Ferdinand Roelfsema; Paul Aoun; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2016-08-22       Impact factor: 5.958

4.  Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.

Authors:  P Putignano; M Bertolini; M Losa; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2003-06       Impact factor: 4.256

5.  Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome.

Authors:  L M Fatti; B Bottasso; C Invitti; R Coppola; F Cavagnini; P M Mannucci
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 5.467

6.  Ultradian cortisol pulsatility encodes a distinct, biologically important signal.

Authors:  Andrew McMaster; Maryam Jangani; Paula Sommer; Namshik Han; Andy Brass; Stephen Beesley; Weiqun Lu; Andrew Berry; Andrew Loudon; Rachelle Donn; David W Ray
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

7.  Phenotypic spectrum of polycystic ovary syndrome and their relationship to the circadian biomarkers, melatonin and cortisol.

Authors:  Audrey J R Lim; Inthrani R Indran; Michael S Kramer; Eu-Leong Yong
Journal:  Endocrinol Diabetes Metab       Date:  2019-03-22

Review 8.  Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth.

Authors:  Joselyn Rojas; Mervin Chávez; Luis Olivar; Milagros Rojas; Jessenia Morillo; José Mejías; María Calvo; Valmore Bermúdez
Journal:  Int J Reprod Med       Date:  2014-01-28

9.  Adrenocortical production is associated with higher levels of luteinizing hormone in nonobese women with polycystic ovary syndrome.

Authors:  Luciana Tock; Gláucia Carneiro; Andrea Z Pereira; Sérgio Tufik; Maria Teresa Zanella
Journal:  Int J Endocrinol       Date:  2014-05-07       Impact factor: 3.257

Review 10.  The Importance of Sleep Hygiene in Polycystic Ovary Syndrome from the View of Iranian Traditional Medicine and Modern Medicine.

Authors:  Maryam Bahman; Homa Hajimehdipoor; Maryam Afrakhteh; Soodabeh Bioos; Fataneh Hashem-Dabaghian; Mojgan Tansaz
Journal:  Int J Prev Med       Date:  2018-10-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.